Direct binding of chloroquine to the multidrug resistance protein (MRP). Possible role for MRP in chloroquine drug transport and resistance in tumor cells

Biochemical Pharmacology

Volumn 56, Issue 6, 1998, Pages 733-742

  Vezmar, Marko ^a   Georges, Elias ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Chloroquine; Drug transport; Multidrug resistance; Multidrug resistance protein (MRP); Photoaffinity labeling

Indexed keywords

CHLOROQUINE; LEUKOTRIENE C4; MULTIDRUG RESISTANCE PROTEIN; VERLUKAST; VINBLASTINE;

ARTICLE; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG TRANSPORT; HUMAN; HUMAN CELL; MEMBRANE BINDING; PHOTOAFFINITY LABELING; PRIORITY JOURNAL;

ANTIMALARIALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; CHLOROQUINE; DRUG RESISTANCE, MULTIPLE; HL-60 CELLS; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROTEIN BINDING; QUINOLINES; SALICYLATES;

EID: 0032530924     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00217-2     Document Type: Article

References (70)

1. Endicott J.A., Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem. 58:1989;137-171.
2. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 62:1993;385-427.
3. Shapiro A.B., Ling V. Reconstitution of drug transport by purified P-glycoprotein. J Biol Chem. 270:1995;16167-16175.
4. Doige C.A., Yu X., Sharom F.J. ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. Biochim Biophys Acta. 1109:1992;149-160.
5. van Helvoort A., Smitt J.H., Sprong A., Fritzsche I., Schinkel A.H., Borst P., Meer G.-V. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell. 87:1996;507-517.
6. Metherall J.E., Li H., Waugh K. Role of multidrug resistance P-glycoprotein in cholesterol biosynthesis. J Biol Chem. 271:1996;2634-2640.
7. Borst P., Schinkel A.H., Smit J.J.M., Wagenaar E., Vandeemte R.L., Smith A.J., Eijdems E.W.H.M., Baas F., Zaman J.G.R. Classical and novel forms of multidrug-resistance and the physiological functions of P-glycoproteins in mammals. Pharmacol Ther. 60:1993;289-299.
8. Schinkel A.H., Smit J.J.M., van Tellingen O., Beijnen J.H., Wagenaar E., van Deemter L., Mol C.A.A.M., van der Valk M.A., Robanus-Maandag E.C., te Riele H.P.J., Berns A.J.M., Borst P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 77:1994;491-502.
9. Schinkel A.H., Mayer U., Wagenaar E., Mol C.A.A.M., van Deemter L., Smit J.J.M., van der Valk M.A., Voordouw A.C., Spits H., van Tellingen O., Zijlmans J.M.J.M., Fibbe W.E., Borst P. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA. 94:1997;4028-4033.
10. Cole S.P.C., Bharswaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M.V., Deeley R.G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 258:1992;1650-1654.
11. Cole S.P., Deeley R.G. Multidrug resistance associated with overexpression of MRP. Cancer Treat Res. 87:1996;39-62.
12. Hyde S.C., Emsley P., Hartshorn M.J., Mimmack M.M., Gileadi U., Pearce S.R., Gallagher M.P., Gill D.R., Hubbard R.E., Higgins C.F. Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature. 346:1990;362-365.
13. Higgins C.F. ABC transporters From microorganisms to man . Annu Rev Cell Biol. 8:1992;67-113.
14. Zaman G.J.R., Flens M.J., Vanleusden M.R., Dehaas M., Mulder H.S., Lankelma J., Pinedo H.M., Scheper R.J., Baas F., Broxterman H.J., Borst P. The human multidrug resistance-associated protein MRP is a plasma-membrane drug-efflux pump. Proc Natl Acad Sci USA. 91:1994;8822-8826.
15. Gros P., Neriah Y.B., Croop J.M., Housman D.E. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature. 323:1986;728-731.
16. Cole S.P., Sparks K.E., Fraser K., Loe D.W., Grant C.E., Wilson G.M., Deeley R.G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 54:1994;5902-5910.
17. Ueda K., Cardarelli C., Gottesman M.M., Pastan I. Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA. 84:1987;3004-3008.
18. Nielsen D., Maare C., Skovsgaard T. Kinetics of daunorubicin transport in Ehrlich ascites tumor cells with different expression of P-glycoprotein. Biochem Pharmacol. 47:1994;2125-2135.
19. Borst P., Kool M., Evers R. Do cMOATS (MRP2), other MRP homologues, and LRP play a role in MDR? Semin Cancer Biol. 8:1997;205-213.
20. Zaman G.J.R., Versantvoort C.H.M., Smit J.J.M., Eijdems E.W.H.M., de Haas M., Smith A.J., Broxterman H.J., Mulder N.H., de Vries E.G.E., Baas F., Borst P. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res. 53:1993;1747-1750.
21. 4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. J Biol Chem. 271:1996;9675-9682.
22. Loe D.W., Almquist K.C., Cole S.P.C., Deeley R.G. ATP-dependent 17β-estradiol 17-(β-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids. J Biol Chem. 271:1996;9683-9689.
23. Rappa G., Lorico A., Flavell R.A., Sartorelli A.C. Evidence that multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res. 57:1997;5232-5237.
24. Lorico A., Rappa G., Finch R.A., Yang D., Flavell R.A., Sartorelli A.C. Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res. 57:1997;5238-5242.
25. Jedlitschky G., Leier I., Buchholz U., Barnouin K., Kurz G., Keppler D. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res. 56:1996;988-994.
26. Leier I., Jedlitschky G., Buchholz U., Center M., Cole S.P.C., Deeley R.G., Keppler D. ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump. Biochem J. 314:1996;433-437.
27. Muller M., Meijer C., Zaman G.J., Borst P., Scheper R.J., Mulder N.H., de Vries E.G.E., Jansen P.L.M. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA. 91:1994;13033-13037.
28. 4 and structurally related conjugates. J Biol Chem. 269:1994;27807-27810.
29. Vezmar M., Deady L.W., Tilley L., Georges E. The quinoline-based drug, N-{4-[1-hydroxy-2-(dibutylamino)ethyl] quinolin-8-yl}-4-azidosalicylamide, photoaffinity labels the multidrug resistance protein (MRP) at a biologically relevant site. Biochem Biophys Res Commun. 241:1997;104-111.
30. 4 receptor antagonist . Can J Physiol Pharmacol. 67:1989;17-28.
31. Cole S.P.C., Downes H.F., Slovak M.L. Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein. Br J Cancer. 59:1989;42-46.
32. Beck W.T., Cirtain M.C., Danks M.K., Felsted R.L., Safa A.R., Wolverton J.S., Suttle D.P., Trent J.M. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells. Cancer Res. 47:1987;5455-5460.
33. Foote S.J., Thompson J.K., Cowman A.F., Kemp D.J. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell. 57:1989;921-930.
34. Ruetz S., Delling U., Brault M., Schurr E., Gros P. The pfmdr1 gene of Plasmodium falciparum confers cellular resistance to antimalarial drugs in yeast cells. Proc Natl Acad Sci USA. 93:1996;9942-9947.
35. van Es H.H.G., Karcz S., Chu F., Cowman A.F., Vidal S., Gros P., Schurr E. Expression of the plasmodial pfmdr1 gene in mammalian cells is associated with increased susceptibility to chloroquine. Mol Cell Biol. 14:1994;2419-2428.
36. Cowman A.F., Galatis D., Thompson J.K. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc Natl Acad Sci USA. 91:1994;1143-1147.
37. Wellems T.E., Walker-Jonah A., Panton L.J. Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7. Proc Natl Acad Sci USA. 88:1991;3382-3386.
38. Awad-el-Kariem F.M., Miles M.A., Warhurst D.C. Chloroquine-resistant plasmodium falciparum isolates from the Sudan lack two mutations in the pfmdr1 gene thought to be associated with chloroquine resistance. Trans R Soc Trop Med Hyg. 86:1992;587-589.
39. Basco L.K., de Pecoulas P.E., Le Bras J., Wilson C.M. Plasmodium falciparum Molecular characterization of multidrug-resistant Cambodian isolates . Exp Parasitol. 82:1996;97-103.
40. Lin P.H., Selinfreund R., Wakshull E., Wharton W. Rapid and efficient purification of plasma membrane from cultured cells Characterization of epidermal growth factor binding . Biochemistry. 26:1987;731-736.
41. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
42. Nare B., Prichard R.K., Georges E. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells. Mol Pharmacol. 45:1994;1145-1152.
43. Fairbanks G., Steck T.L., Wallach D.F.H. Electrophoretic analysis of major polypeptides of the human erythrocyte membrane. Biochemistry. 10:1971;2606-2617.
44. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets Procedure and some applications . Proc Natl Acad Sci USA. 76:1979;4350-4354.
45. r 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cells. Cancer Res. 55:1995;102-110.
46. Marquardt D., McCrone S., Center M.S. Mechanisms of multidrug resistance in HL60 cells Detection of resistance-associated proteins with antibodies against synthetic peptides that correspond to the deduced sequence of P-glycoprotein . Cancer Res. 50:1990;1426-1430.
47. Nare B., Liu Z., Prichard R.K., Georges E. Benzimidazoles, potent anti-mitotic drugs Substrates for the P-glycoprotein transporter in multidrug-resistant cells . Biochem Pharmacol. 48:1994;2215-2222.
48. 1 and its glutathione conjugates by the product of the multidrug resistance protein (MRP) gene. Mol Pharmacol. 51:1997;1034-1041.
49. Asakura T., Takahashi N., Takada K., Inoue T., Ohkawa K. Drug conjugate of doxorubicin with glutathione is a potent reverser of multidrug resistance in rat hepatoma cells. Anticancer Drugs. 8:1997;199-203.
50. Zamora J.M., Pearce H.L., Beck W.T. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol Pharmacol. 33:1988;454-462.
51. 4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem Biophys Res Commun. 208:1995;345-352.
52. Feller N., Kuiper C.M., Lankelma J., Ruhdal J.K., Scheper R.J., Pinedo H.M., Broxterman H.J. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry. Br J Cancer. 72:1995;543-549.
53. Lautier D., Canitrot Y., Deeley R.G., Cole S.P.C. Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochem Pharmacol. 52:1996;967-977.
54. Marsh W., Sicheri D., Center M.S. Isolation and characterization of adriamycin-resistant HL-60 cells which are not defective in the initial intracellular accumulation of drug. Cancer Res. 46:1986;4053-4057.
55. Schneider E., Horton J.K., Yang C.H., Nakagawa M., Cowan K.H. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res. 54:1994;152-158.
56. Cole S.P., Chanda E.R., Dicke F.P., Gerlach J.H., Mirski S.E. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line Evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II . Cancer Res. 51:1991;3345-3352.
57. Mirski S.E.L., Cole S.P.C. Multidrug resistance-associated antigens on drug-sensitive and -resistant human tumour cell lines. Br J Cancer. 64:1991;15-22.
58. +)-adenosine triphosphatase activity in multidrug resistance in HL60 cells. J Natl Cancer Inst. 83:1991;1098-1102.
59. Wang Y., Pan X.-Q., Lheureux F., Georges E. Overexpression of 40-kDa protein in human multidrug resistant cells. Biochem Biophys Res Commun. 236:1997;483-488.
60. Cowman A.F. Mechanisms of drug resistance in malaria. Aust N Z J Med. 25:1995;837-844.
61. Foley M., Tilley L. Quinoline antimalarials Mechanisms of action and resistance . Int J Parasitol. 27:1997;231-240.
62. Yayon A., Cabantchik Z.I., Ginsburg H. Susceptibility of human malaria parasites to chloroquine is pH dependent. Proc Natl Acad Sci USA. 82:1985;2784-2788.
63. Krogstad D.J., Gluzman I.Y., Herwaldt B.L., Schlesinger P.H., Wellems T.E. Energy dependence of chloroquine accumulation and chloroquine efflux in Plasmodium falciparum. Biochem Pharmacol. 43:1992;57-62.
64. Wellems T.E., Panton L.J., Gluzman I.Y., do Rosario V.E., Gwadz R.W., Walker-Jonah A., Krogstad D.J. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature. 345:1990;253-255.
65. Lim A.S., Cowman A.F. Plasmodium falciparum Chloroquine selection of a cloned line and DNA rearrangements . Exp Parasitol. 83:1996;283-294.
66. Lim A.S.Y., Galatis D., Cowman A.F. Plasmodium falciparum Amplification and overexpression of pfmdr1 is not necessary for increased mefloquine resistance . Exp Parasitol. 83:1996;295-303.
67. Papadopoulou B., Roy G., Dey S., Rosen B.P., Ouellette M. Contribution of the Leishmania P-glycoprotein-related gene 1tpgpA to oxyanion resistance. J Biol Chem. 269:1994;11980-11986.
68. Callahan H.L., Beverley S.M. Heavy metal resistance A new role of P-glycoproteins in Leishmania . J Biol Chem. 266:1991;18427-18430.
69. Szczypka M.S., Wemmie J.A., Moye-Rowley W.S., Thiele D.J. A yeast metal resistance protein similar to human cystic fibrosis transmembrane conductance regulator (CFTR) and multidrug resistance-associated protein. J Biol Chem. 269:1994;22853-22857.
70. Broeks A., Gerrard B., Allikmets R., Dean M., Plasterk R.H.A. Homologues of the human multidrug resistance genes MRP and MDR contribute to heavy metal resistance in the soil nematode Caenorhabditis elegans. EMBO J. 15:1996;6132-6143.